Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2ATHENA

02 4TRIS PHARMA INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAthena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

Patent Expiration Date : 2027-04-17

CLONIDINE

US Patent Number : 8337890

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22500

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-04-17

Athena Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAthena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

Patent Expiration Date : 2027-04-17

CLONIDINE

US Patent Number : 8337890

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22500

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-04-17

Athena Company Banner

03

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE

US Patent Number : 8337890

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210526

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-03-15

blank

04

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE

US Patent Number : 8337890

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210526

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-03-15

blank

05

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE

US Patent Number : 8337890

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210526

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-03-15

blank

06

arrow
Pharmtech & Ingredients
Not Confirmed
arrow
Pharmtech & Ingredients
Not Confirmed

AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE

US Patent Number : 8337890

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210526

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-03-15

blank